{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:20:10Z","timestamp":1769602810035,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.clgc.2017.09.009","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T06:17:22Z","timestamp":1506147442000},"page":"135-141.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short-term Luteinizing Hormone-releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate-risk Prostate Cancer: Preliminary Prospective Study"],"prefix":"10.1016","volume":"16","author":[{"given":"Takahiro","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8135-8746","authenticated-orcid":false,"given":"Takashi","family":"Mizowaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daijiro","family":"Kabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinari","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8660-4363","authenticated-orcid":false,"given":"Kiyonao","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2017.09.009_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ctrv.2016.03.016","article-title":"Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: a systematic review of the literature","volume":"46","author":"Zilli","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clgc.2017.09.009_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2017.09.009_bib3","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1002\/cncr.29672","article-title":"Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners","volume":"121","author":"Donovan","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2017.09.009_bib4","first-page":"291","article-title":"Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer","volume":"13","author":"Shahidi","year":"2001","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clgc.2017.09.009_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0360-3016(01)02604-9","article-title":"Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer","volume":"52","author":"Padula","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2017.09.009_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1464-410X.2006.06013.x","article-title":"Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer","volume":"97","author":"Murthy","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2017.09.009_bib7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s10147-005-0519-4","article-title":"Comparison of three radiotherapy treatment planning protocols of definitive external-beam radiation for localized prostate cancer","volume":"10","author":"Zhu","year":"2005","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clgc.2017.09.009_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10147-011-0324-1","article-title":"Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol","volume":"17","author":"Norihisa","year":"2012","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clgc.2017.09.009_bib9","first-page":"1856","article-title":"Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the Expanded Prostate Cancer Index Composite","volume":"177","author":"Kakehi","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2017.09.009_bib10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10147-016-0954-4","article-title":"Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer","volume":"21","author":"Mizowaki","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clgc.2017.09.009_bib11","first-page":"1567","article-title":"A\u00a0prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapy","volume":"173","author":"Gulley","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2017.09.009_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/aja.2012.169","article-title":"Kinetics of testosterone recovery in clinically localized prostate cancer patients treated with radical prostatectomy and subsequent short-term adjuvant androgen deprivation therapy","volume":"15","author":"Dai","year":"2013","journal-title":"Asian J Androl"},{"key":"10.1016\/j.clgc.2017.09.009_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/00365590600641533","article-title":"Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer","volume":"40","author":"Kobayashi","year":"2006","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.clgc.2017.09.009_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4329\/wjr.v7.i12.494","article-title":"Recovery of serum testosterone following neoadjuvant and adjuvant androgen deprivation therapy in men treated with prostate brachytherapy","volume":"7","author":"Tsumura","year":"2015","journal-title":"World J Radiol"},{"key":"10.1016\/j.clgc.2017.09.009_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.meddos.2016.07.004","article-title":"Dosimetric analysis of testicular doses in prostate intensity-modulated and volumetric-modulated arc radiation therapy at different energy levels","volume":"41","author":"Onal","year":"2016","journal-title":"Med Dosim"},{"key":"10.1016\/j.clgc.2017.09.009_bib16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12885-016-2737-8","article-title":"A\u00a0comparative study on the efficacies of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist in neoadjuvant androgen deprivation therapy combined with transperineal prostate brachytherapy for localized prostate cancer","volume":"16","author":"Miki","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clgc.2017.09.009_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/pcan.2015.50","article-title":"Influence of 1 year of androgen deprivation therapy on lipid and glucose metabolism and fat accumulation in Japanese patients with prostate cancer","volume":"19","author":"Mitsuzuka","year":"2016","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clgc.2017.09.009_bib18","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.urology.2014.02.006","article-title":"Weight gain on androgen deprivation therapy: which patients are at highest risk?","volume":"83","author":"Seible","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2017.09.009_bib19","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1464-410X.2005.05676.x","article-title":"Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study","volume":"96","author":"Malone","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2017.09.009_bib20","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s11136-013-0603-6","article-title":"Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer","volume":"23","author":"Yamamoto","year":"2014","journal-title":"Qual Life Res"},{"key":"10.1016\/j.clgc.2017.09.009_bib21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.pcan.4500923","article-title":"Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy","volume":"10","author":"Yoshimura","year":"2007","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clgc.2017.09.009_bib22","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clgc.2017.09.009_bib23","first-page":"418","article-title":"PURLS: it's time to reconsider early-morning testosterone tests","volume":"64","author":"Long","year":"2015","journal-title":"J\u00a0Fam Pract"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767317302847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767317302847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:28:29Z","timestamp":1761564509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767317302847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1558767317302847"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2017.09.009","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short-term Luteinizing Hormone-releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate-risk Prostate Cancer: Preliminary Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2017.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}